News Releases

West Point Lists on the CSE under the Symbol: BLO

June 25, 2014

Vancouver, British Columbia, June 25, 2014: West Point Resources Inc. (CSE: BLO) (the “Company”) announces the Canadian Securities Exchange (CSE) has approved the listing of West Point Resources Inc’s common shares on the CSE. The company will begin trading on the CSE at the open on Thursday, June 26, 2014, under the symbol "BLO".

On June 16, 2014, West Point announced it had entered into a definitive agreement with Cannabix Breathalyzer Inc. to license the North American rights to the Cannabix marijuana breathalyzer.   The company’s private placement announced on May 15, 2014 has been oversubscribed and is expected to close shortly.

Kal Malhi, President of West Point states, “We have been pleased with the tremendous support West Point has received in the media and from investors in funding this exciting marijuana breath testing technology”.  

West Point is the developer of the Cannabix marijuana breathalyzer for law enforcement. The Cannabix marijuana breathalyzer provides rapid detection of THC and can be used roadside to identify drivers intoxicated by the use of marijuana. The device can also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.

West Point Resources will be applying for a listing of its shares for trading on the U.S. OTC markets. The Company will provide further updates in due course. 

We seek Safe Harbor.  

The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.